Renovia

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Renovia sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting 3 completed upper quartile by trial count

Renovia: 3 sponsored US clinical trials, none currently recruiting.

Renovia sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Stress Urinary Incontinence, with 1 trials.

Upper-quartile sponsor footprint

Renovia sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

3 total, page 1 of 1

COMPLETED NA

Pelvic Floor Muscle Training With a Digital Therapeutic Device to Standard Exercises for Stress Urinary Incontinence

NCT04508153
COMPLETED NA

Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence

NCT03632447
COMPLETED NA

Use of the Leva Incontinence System in Treating Bladder Incontinence.

NCT03536923

Therapeutic Areas

Stress Urinary Incontinence 1

How the Renovia archive is shaped

3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Stress Urinary Incontinence (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Renovia: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Renovia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Renovia10xBio22nd Century GroupAA SecordAAADRS Clinical Research Center23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
Renovia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Renovia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Renovia page

3 registered trials is a research-attention snapshot, not an endorsement of Renovia or any single study.

  • None of Renovia's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Stress Urinary Incontinence is the condition Renovia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stress Urinary Incontinence trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Renovia pipeline card: 3 registered trials from official public datasets.Report a data error.